Tadilecto Special Precautions

Talk to the doctor or pharmacist before taking Tadilecto.
Be aware that sexual activity carries a possible risk to patients with heart disease because it puts an extra strain on the heart. If the patient has a heart problem he should tell the doctor.
Before taking the tablets, the patient should tell the doctor if he has: sickle cell anemia (an abnormality of red blood cells); multiple myeloma (cancer of the bone marrow); leukaemia (cancer of the blood cells); any deformation of the penis; a serious liver problem; a severe kidney problem.
It is not known if Tadilecto is effective in patients who have had: pelvic surgery; removal of all or part of the prostate gland in which nerves of the prostate are cut (radical non-nerve-sparing prostatectomy).
If the patient experiences sudden decrease or loss of vision, he should stop taking Tadilecto and contact the doctor immediately.
Decreased or sudden hearing loss has been noted in some patients taking tadalafil. Although it is not known if the event is directly related to tadalafil, if the patient experiences decreased or sudden hearing loss, he should stop taking Tadilecto and contact the doctor immediately.
Tadilecto is not intended for use by women.
Tadilecto with drink and alcohol: Information on the effect of alcohol is in Dosage & Administration.
Grapefruit juice may affect how well Tadilecto will work and should be taken with caution.
Talk to the doctor for further information.
Fertility: When dogs were treated there was reduced sperm development in the testicles. A reduction in sperm was seen in some men. These effects are unlikely to lead to a lack of fertility.
Tadilecto contains lactose: If the patient has been told by the doctor that he has an intolerance to some sugars, the patient should contact the doctor before taking this medicine.
Driving and using machines: Some men taking tadalafil in clinical studies have reported dizziness. Check carefully how the patient reacts to the medicine before driving or using machines.
Use in Children: Tadilecto is not indicated for use by children and adolescents under the age of 18.